==== Front Korean J RadiolKorean J RadiolKJRKorean Journal of Radiology1229-69292005-8330The Korean Society of Radiology 10.3348/kjr.2018.19.5.897Breast ImagingOriginal ArticleIdentification of Preoperative Magnetic Resonance Imaging Features Associated with Positive Resection Margins in Breast Cancer: A Retrospective Study Kang Jung-Hyun MD1Youk Ji Hyun MDPhD1Kim Jeong-Ah MDPhD1Gweon Hye Mi MDPhD1Eun Na Lae MD1Ko Kyung Hee MD2Son Eun Ju MDPhD11 Department of Radiology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06273, Korea.2 Department of Diagnostic Radiology, CHA Bundang Medical Center, CHA University, Seongnam 13496, Korea.Corresponding author: Eun Ju Son, MD, PhD, Department of Radiology, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 06273, Korea. Tel: (822) 2019-3510, Fax: (822) 3462-5472, EJSONRD@yuhs.acSep-Oct 2018 06 8 2018 19 5 897 904 15 8 2017 14 3 2018 Copyright © 2018 The Korean Society of Radiology2018The Korean Society of RadiologyThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Objective To determine which preoperative breast magnetic resonance imaging (MRI) findings and clinicopathologic features are associated with positive resection margins at the time of breast-conserving surgery (BCS) in patients with breast cancer. Materials and Methods We reviewed preoperative breast MRI and clinicopathologic features of 120 patients (mean age, 53.3 years; age range, 27–79 years) with breast cancer who had undergone BCS in 2015. Tumor size on MRI, multifocality, patterns of enhancing lesions (mass without non-mass enhancement [NME] vs. NME with or without mass), mass characteristics (shape, margin, internal enhancement characteristics), NME (distribution, internal enhancement patterns), and breast parenchymal enhancement (BPE; weak, strong) were analyzed. We also evaluated age, tumor size, histology, lymphovascular invasion, T stage, N stage, and hormonal receptors. Univariate and multivariate logistic regression analyses were used to determine the correlation between clinicopathological features, MRI findings, and positive resection margins. Results In univariate analysis, tumor size on MRI, multifocality, NME with or without mass, and segmental distribution of NME were correlated with positive resection margins. Among the clinicopathological factors, tumor size of the invasive breast cancer and in situ components were significantly correlated with a positive resection margin. Multivariate analysis revealed that NME with or without mass was an independent predictor of positive resection margins (odds ratio [OR] = 7.00; p < 0.001). Strong BPE was a weak predictor of positive resection margins (OR = 2.59; p = 0.076). Conclusion Non-mass enhancement with or without mass is significantly associated with a positive resection margin in patients with breast cancer. In patients with NME, segmental distribution was significantly correlated with positive resection margins. Breast cancerBreast-conserving surgeryMRIBI-RADSResection margin ==== Body INTRODUCTION Overall survival after breast-conserving surgery (BCS) and adjuvant breast irradiation is equivalent to that after mastectomy for stage I or II breast cancer (12). However, the probability of local recurrence is higher in patients treated with BCS compared with those undergoing radical mastectomy (2). A positive resection margin at the time of BCS is associated with a substantially higher local recurrence rate (345). A positive resection margin is defined by the presence of invasive carcinoma or ductal carcinoma in situ (DCIS) at the inked margin of the resected specimen (46). In previous studies, several factors such as younger age, larger tumor size, positive lymph nodes, multifocal tumors, lobular histology, and the percentage of in situ components were associated with a positive resection margin (789101112). Breast magnetic resonance imaging (MRI) has been widely used for the preoperative evaluation of tumor extent in patients with confirmed breast cancer. Previous studies reported that preoperative breast MRI altered the surgical management in approximately 20–30% of patients with breast cancer, leading to a decrease in reoperation rates and an increase in radical mastectomy rates (1314). The high sensitivity of breast MRI for cancer detection is presumed to improve the selection of patients for BCS and decrease the rates of a positive resection margin at the first BCS attempt (15). However, there is increasing concern that false-positive findings on preoperative MRI may lead to overtreatment in patients switching from BCS to radical mastectomy, without a clear survival benefit. Therefore, it is important to determine the preoperative MRI findings and clinicopathological features associated with a positive resection margin during BCS. The purpose of our study was to determine the factors that are associated with a positive resection margin at the time of BCS in patients with breast cancer, with an emphasis on preoperative breast MRI findings. MATERIALS AND METHODS Patients This retrospective study was approved by our Institution (Gangnam Severance Hospital) Review Board for clinical studies, and the need for obtaining individual consent from the subjects was waived. Between January 2015 and December 2015, we identified 153 consecutive women who had undergone BCS due to breast cancer, invasive cancer, or DCIS, and screened with preoperative MRI. Women receiving chemotherapy prior to surgery (n = 2), those who underwent local excisional biopsy before preoperative MRI (n = 24), and those lacking medical records associated with human epidermal growth factor receptor 2 (HER2) status (n = 7) were excluded. Finally, a total of 120 patients who had undergone BCS (mean age, 53.3 years; age range, 27–79 years) were included in our study. Histopathologic and Immunohistochemical Analysis Final histopathological results of the surgical specimens were reviewed to determine the tumor size of both the invasive component alone, and the invasive and in situ components, the presence or absence of lobular histology, lymphovascular invasion (LVI), and immunohistochemical status. If the final diagnosis was DCIS, the size of the invasive component was recorded as zero. Estrogen receptor (ER) and progesterone receptor (PR) expression was recorded (negative or positive). HER2/neu (HER2) staging was scored as 0 (negative; no staining), 1+ (negative; faint/barely perceptible incomplete membrane staining), 2+ (equivocal; weak-to-moderate complete membrane staining in > 10% of the tumor cells or strong complete membrane staining in < 30% of the tumor cells), or 3+ (positive; strong complete membrane staining in > 30% of the tumor cells) according to the guidelines of the American Society of Clinical Oncology/College of American Pathologists (16). Tumors scoring 2+ required further examination using silver-enhanced in situ hybridization (SISH) to measure HER2 amplification. A HER2/chromosome 17 ratio greater than 2.2 by SISH indicated HER2 positive status. TNM staging was also conducted based on the seventh American Joint Committee on Cancer guidelines (17). Sentinel node biopsies or axillary nodal dissections were performed, and the N stage was recorded. Lesion Localization and Evaluation of Resection Margin Preoperative tumor localization for nonpalpable lesions was performed by two radiologists (with 5 years and 9 years of experience in breast imaging, respectively) with either mammographically or ultrasound-guided wire placement into the tumor. In cases of non-palpable tumors with microcalcifications, specimen mammography was performed to confirm adequate resection. Intraoperative margin excision and frozen section analysis were performed to evaluate intraoperative margins in all patients. A positive surgical margin was defined as the presence of tumor cells at the inked surface of the resected specimen. The margin was considered negative, in the absence of cancer cells on the inked surface of the resected specimen. We classified the following cases as a positive resection margin: 1) re-excision for positive frozen section analysis during BCS, 2) conversion from attempted BCS to mastectomy, and 3) requirement for further surgical excision. MR Technique Breast MRI was performed using a 3T system (Achieva, Philips Medical System, Best, the Netherlands; Discovery MR 750, GE Healthcare, Waukesha, WI, USA) with a dedicated, sensitivity encoding (SENSE), four-channel breast coil. All images were acquired with bilateral axial views in the prone position. The protocol included turbo spin-echo T1- and T2-weighted images and T2-weighted fat suppressed spin-echo series. Dynamic contrast-enhanced MRI was performed with one pre-contrast and five post-contrast dynamic series using a fat-suppressed T1-weighted gradient echo sequence (TR/TE: 4.9/2.4; matrix, 340 x 340; flip angle, 12°; field of view, 34 x 34 cm; slice thickness, 1.5 mm). The acquisition time of each post-contrast series was 74 seconds after a bolus injection of 0.1 mmol gadobutrol (Gadovist, Bayer Healthcare, Berlin, Germany) per kilogram of body weight via an automated injector (Nemoto, Nemoto Kyorindo, Tokyo, Japan), at a rate of 2 mL/s, followed by a 20-mL saline flush. After the examination, subtraction images were obtained by subtracting the unenhanced images from all contrast-enhanced images. MRI Analysis Two radiologists (with 5 years and 20 years of experience in breast MRI interpretation, respectively) reviewed the breast MR images in consensus according to the American College of Radiology breast imaging reporting and data system (ACR BIRADS) MRI lexicon (18). The largest diameters of enhancing lesions were measured in the axial plane of early post-contrast fat-suppressed T1-weighted images and subtraction images. Multifocal cancer was defined as the presence of two or more cancer lesions in the same quadrant, which were separated by normal breast parenchyma. In cases of multifocal lesions, the maximal diameter was not the sum of their diameters, but rather the single largest diameter measured. According to the ACR BIRADS MRI lexicon, enhancing lesions were divided into 2 categories: a mass including foci and non-mass enhancement (NME). We categorized the 120 cases into 2 groups based on the patterns of enhancing lesions on breast MRI. These groups included: 1) mass without NME, 2) NME with or without mass. In patients with a mass, we additionally categorized the shape, margin, and internal enhancement of the mass according to the following criteria: 1) shape (oval, round, or irregular), 2) margin (circumscribed, irregular, or spiculated), and 3) internal enhancement (homogeneous, heterogeneous, rim enhancement, or dark internal septations). In patients with NME, we analyzed the distribution and internal enhancement patterns of the NME according to the following criteria: 1) distribution (focal, linear, segmental, or regional) and 2) internal enhancement patterns (homogeneous, heterogeneous, clumped, or clustered ring). We also assessed breast parenchymal enhancement (BPE) using post-contrast fat-suppressed T1-weighted images and subtraction images. BPE was categorized as minimal, mild, moderate, or marked, and dichotomized into weak (minimal or mild) or strong (moderate or marked) enhancement for statistical analysis. Statistical Analysis The chi-squared test or Fisher's exact test was used to identify the association between each of the preoperative breast MRI findings or clinicopathological factors and the rate of positive resection margins. An independent two-sample t test was used for continuous normally distributed variables. Multivariate analysis was performed using logistic regression analysis of statistically significant variables (p < 0.100) via univariate analysis, and the odds ratios (ORs) were estimated. We considered p values less than 0.05 as statistically significant. SAS software (version 9.2, SAS Institute Inc., Cary, NC, USA) was used to perform the statistical analyses. RESULTS The final histopathological results of the surgical specimens revealed invasive ductal carcinoma in 88 cases, DCIS in 8, invasive cribriform carcinoma in 6, mucinous carcinoma in 5, invasive lobular carcinoma in 3, medullary carcinoma in 3, apocrine carcinoma in 2, microinvasive ductal carcinoma with lobular carcinoma in 1, invasive solid papillary carcinoma in 1, high-grade sarcoma in 1, glycogen-rich clear cell carcinoma in 1, and metaplastic carcinoma in 1 case. Among the 120 patients, 31 (25.8%) showed a positive resection margin, and 89 (74.2%) had a negative resection margin. Among the 31 cases with a positive resection margin, 17 (54.8%) underwent re-excision for positive frozen section analysis during BCS, 8 (25.8%) received additional local excision, and 6 (19.4%) underwent converted total mastectomy from attempted BCS. The mean tumor size of invasive and in situ component was significantly larger in the positive resection margin group compared with the negative resection margin group (2.7 cm vs. 1.8 cm; p = 0.015). Age, size of the invasive component of breast cancer, lobular histology, LVI, T stage, N stage, ER, PR, and HER2 status were not associated with positive resection margins (Table 1). The mean tumor size and multifocality of the tumor on MRI were associated with a positive resection margin (p = 0.048, p = 0.047, respectively). Patterns of enhancing lesions were also significantly associated with a positive resection margin (p < 0.001). Patients with a positive resection margin manifested a higher rate of NME with or without mass on preoperative breast MRI (61.3%) (Fig. 1). However, patients with a negative resection margin had a lower rate of NME with or without mass (14.6%). In cases with NME, the distribution was significantly associated with a positive resection margin (p = 0.024). Strong BPE was associated with a positive resection margin (p = 0.087) (Table 2). Univariate logistic regression analysis of clinicopathological features revealed that the size of the invasive as well as in situ component of the tumor was associated with a positive resection margin (OR = 1.97; p = 0.004) (Table 3). Table 4 summarizes the results of univariate logistic regression analysis of MRI findings. Tumor size, multifocality, and NME with or without mass were associated with positive resection margins (OR = 1.63; p = 0.015, OR = 3.42; p = 0.035, OR = 9.26; p < 0.001, respectively). In particular, NME with segmental distribution was strongly associated with a positive resection margin (OR = 11.96, p = 0.025). Patterns of enhancing lesions were significantly associated with a positive resection margin. In terms of patterns of enhancing lesions, NME with or without mass was independently predictive of a positive resection margin (OR = 7.00; p < 0.001). Strong BPE was also a weak predictor of positive resection margin (OR = 2.59; p = 0.076) (Table 5). DISCUSSION Currently, BCS is the standard treatment for breast cancer in its early stages. However, a positive resection margin at the time of BCS is associated with a considerably higher risk of local tumor recurrence (34). The rate of positive resection margin in our study was 25.8% (31/120) which was within the reported range of 20–70% in the literature (319). Larger tumor size, lobular histology, presence of in situ components, younger age, multifocal lesions, and LVI are associated with a positive margin (789101112). Consistent with previous reports, the size of the invasive as well as in situ tumor component was associated significantly with a positive resection margin in our study (OR = 1.97; p = 0.004). However, younger age and lobular histology (only 4 cases out of 120) were not associated with positive resection margin in our study, probably due to the small number of cases. The role of preoperative MRI in reducing the rate of positive resection margin in patients with breast cancer treated with BCS is disputed. Turnbull et al. (20), in a recent randomized controlled trial, reported that addition of preoperative breast MRI was not significantly associated with reduced reoperation rate. Houssami et al. (21), in a meta-analysis of 9 studies, reported that exposure to preoperative breast MRI increased the overall mastectomy rate (25.5% vs. 18.2%; OR, 1.54 [p < 0.001]; adjusted OR, 1.51 [p < 0.001]) and failed to reduce the rate of re-excision surgery in patients with initial breast conservation (11.6% vs. 11.4%; OR, 1.02 [p = 0.87]; adjusted OR, 0.95 [p = 0.71]). On the other hand, Pengel et al. (22) reported that preoperative MRI was significantly associated with a lower rate of incomplete excision in patients with invasive ductal carcinoma. Mann et al. (23) found that preoperative breast MRI reduced the rate of re-excision without increasing the mastectomy rate in patients with invasive lobular carcinoma. With regard to the MRI features associated with resection margin positivity after BCS, according to Kim et al. (24), the single NME group showed the highest re-excision rate after BCS (22.2%, p = 0.02). Jang et al. (25) found that a tumor size exceeding 5 cm (OR = 3.81), NME (OR = 2.96), and multifocal lesions (OR = 2.54) on preoperative MRI were positively associated with re-excision. For NME lesions, the segmental distribution pattern predicted re-excision (OR = 10.53) (25). Similar to a previous study, NME with or without mass was an independent predictor of a positive resection margin compared with mass without NME (OR = 7.00, p < 0.001). Notably, the segmental distribution of NME was strongly associated with a positive resection margin (OR = 11.96, p = 0.025). The association between NME and resection margin positivity might be explained by the presence of a DCIS component manifesting as NME. DCIS more commonly presented as NME than mass and many DCIS lesions exhibit segmental or ductal distribution and a clustered ring or clumped internal enhancement (262728). Furthermore, many studies have reported that the presence of a DCIS component was significantly associated with a positive resection margin (2529303132). Thus, radiologists should be aware that NME on preoperative breast MRI increases the possibility of subsequent positive resection margin status. In this study, multifocal cancer on MRI was correlated with positive resection margin in univariate analysis, but not in multivariate analysis, which might be explained by the routine use of multiple wire localization for multifocal, nonpalpable lesions in our hospital. Additionally, a strong BPE was associated with a positive resection margin with borderline significance (OR = 2.59, p = 0.76) in our study, similar to a previous study in which strong BPE was a significant independent factor for positive resection margin (OR = 2.39) (33). BPE varies in degree and distribution in different patients as well as in the same patient over time. Moderate or marked BPE may yield false-positive or false-negative results, and has been associated with abnormal interpretation compared with minimal or mild BPE, especially in the presence of focal, regional, or asymmetric BPE (3435). Small additional masses or NME around the index cancer may be masked by adjacent enhancing breast tissue leading to a false-negative interpretation (3536). There are several limitations to this study. First, because of its retrospective design, patient selection bias might have occurred. We identified 153 consecutive patients with breast cancer who had undergone preoperative MRI and BCS. The patients whose initial surgical plan was switched from BCS to mastectomy due to unfavorable preoperative MRI findings were excluded. Furthermore, 33 (21.6%) of the 153 patients were excluded because they underwent chemotherapy prior to surgery, had a local excisional biopsy, or lacked medical records showing HER2 status. Second, we did not correlate the MRI findings with the pathologic findings comprehensively. Further studies correlating MRI and pathological findings are needed. In conclusion, this study found that NME with or without mass detected on preoperative breast MRI was an independent predictive factor for a positive resection margin. More specifically, NME with segmental distribution was strongly correlated with a positive resection margin. In addition, strong BPE was associated with a positive resection margin with borderline significance. Among clinicopathologic factors, the size of the invasive and in situ component of the tumor was significantly associated with a positive resection margin. These factors facilitate patient selection and determination of the extent of resection during BCS. Fig. 1 69-year-old woman with invasive solid papillary carcinoma. Preoperative contrast-enhanced T1-weighted subtraction images show segmental clustered ring non-mass enhancement in outer portion of right breast. Patient underwent total mastectomy, which was converted from attempted breast-conserving surgery since positive resection margin was obtained from frozen section analysis. Size of invasive and in situ component of tumor was approximately 3.7 cm. Patient tested positive for estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2. Table 1 Analysis of Associations between Clinicopathologic Factors and Positive Resection Margin Positive Resection Margin (n = 31) Negative Resection Margin (n = 89) P Age (years) 51.3 ± 10.9 54.0 ± 11.4 0.250 Tumor size (cm) (invasive component) 1.5 ± 1.2 1.6 ± 0.8 0.581 Tumor size (cm) (invasive and in situ component) 2.7 ± 1.8 1.8 ± 0.8 0.015 Histology 0.274  Lobular 2 (6.5) 2 (2.3)  Other 29 (93.5) 87 (97.7) Lymphovascular invasion 0.478  Present 7 (22.6) 15 (16.9)  Absent 24 (77.4) 74 (83.1) T stage 0.289  Tis 3 (9.7) 5 (5.6)  T1 20 (64.5) 58 (65.2)  T2 7 (22.6) 26 (29.2)  T3 1 (3.2) 0 (0) N stage 0.894  N0 23 (74.2) 68 (76.4)  N1 6 (19.4) 16 (18.0)  N2 2 (6.4) 4 (4.5)  N3 0 (0) 1 (1.1) Estrogen receptor 0.491  Positive 21 (67.7) 66 (74.2)  Negative 10 (32.3) 23 (25.8) Progesterone receptor 0.740  Positive 16 (51.6) 49 (55.1)  Negative 15 (48.4) 40 (44.9) HER2 0.779  Positive 5 (16.1) 13 (14.6)  Negative 26 (83.9) 76 (85.4) HER2 = human epidermal growth factor receptor 2, Tis = carcinoma in situ Table 2 Analysis of Associations between MRI Findings and Positive Resection Margin Positive Resection Margin (n = 31) Negative Resection Margin (n = 89) P Size on MRI (cm) 2.7 ± 2.2 1.9 ± 0.8 0.048 Multifocality 0.047  Yes 7 (22.6) 7 (7.9)  No 24 (77.4) 82 (92.1) Patterns of enhancing lesions < 0.001  Mass without NME 12 (38.7) 76 (85.4)  NME with or without mass 19 (61.3) 13 (14.6) Mass  Shape 0.923   Oval 9 (33.3) 25 (29.7)   Round 5 (18.5) 15 (17.9)   Irregular 13 (48.2) 44 (52.4)  Margin 0.222   Circumscribed 10 (37.1) 18 (21.4)   Irregular 11 (40.7) 48 (57.2)   Spiculated 6 (22.2) 18 (21.4)  Internal enhancement characteristics 0.470   Homogeneous 4 (14.8) 9 (10.8)   Heterogeneous 17 (63.0) 50 (60.3)   Rim enhancement 6 (22.2) 24 (28.9)   Dark internal septations 0 (0) 0 (0) NME  Distribution 0.024   Focal 4 (21.0) 9 (69.2)   Linear 6 (31.6) 3 (23.1)   Segmental 8 (42.1) 1 (7.7)   Regional 1 (5.3) 0 (0)  Internal enhancement patterns 0.475   Homogeneous 1 (5.3) 0 (0)   Heterogeneous 4 (21.0) 6 (46.15)   Clumped 11 (57.9) 6 (46.15)   Clustered ring 3 (15.8) 1 (7.7)  BPE 0.087   Weak 20 (64.5) 71 (79.8)   Strong 11 (35.5) 18 (20.2) BPE = breast parenchymal enhancement, MRI = magnetic resonance imaging, NME = non-mass enhancement Table 3 Univariate Logistic Regression Analysis of Clinicopathologic Factors for Predicting Positive Resection Margin OR 95% CI P Age (years) 0.98 0.94–1.02 0.249 Tumor size (cm) (invasive component) 0.86 0.54–1.35 0.503 Tumor size (cm) (invasive and in situ component) 1.97 1.24–3.11 0.004 Histology  Lobular 3.00 0.40–22.27 0.283  Other Ref Lymphovascular invasion  Present 1.44 0.53–3.94 0.479  Absent Ref T stage  Tis Ref  T1 0.55 0.12–2.49 0.438  T2 0.45 0.09–2.30 0.334  T3 4.79 0.04–559.56 0.519 N stage  N0 Ref  N1 1.15 0.41–3.25 0.795  N2 1.62 0.29–9.18 0.586  N3 0.93 0.01–92.69 0.974 Estrogen receptor  Positive 0.73 0.30–1.78 0.492  Negative Ref Progesterone receptor  Positive 0.87 0.38–1.98 0.741  Negative Ref HER2  Positive 1.12 0.37–3.46 0.838  Negative Ref CI = confidence interval, OR = odds ratio, Ref = reference Table 4 Univariate Logistic Regression Analysis of MRI Findings for Predicting Positive Resection Margin OR 95% CI P Size on MRI (cm) 1.63 1.10–2.43 0.015 Multifocality  Yes 3.42 1.09–10.71 0.035  No Ref Patterns of enhancing lesions  Mass without NME Ref  NME with or without mass 9.26 3.65–23.50 < 0.001 Mass  Shape   Oval Ref   Round 0.93 0.26–3.29 0.905   Irregular 0.82 0.31–2.19 0.693  Margin   Circumscribed Ref   Irregular 0.41 0.15–1.14 0.087   Spiculated 0.60 0.18–2.00 0.406  Internal enhancement characteristics   Homogeneous Ref   Heterogeneous 0.77 0.21–2.81 0.686   Rim enhancement 0.56 0.13–2.47 0.446 NME  Distribution   Focal Ref   Linear 3.92 0.65–23.66 0.136   Segmental 11.96 1.37–104.62 0.025   Regional 6.89 0.06–813.36 0.428  Internal enhancement patterns   Homogeneous Ref   Heterogeneous 0.23 0.01–25.38 0.538   Clumped 0.58 0.01–60.78 0.818   Clustered ring 0.76 0.01–116.21 0.916  BPE   Weak Ref   Strong 2.17 0.88–5.33 0.091 Table 5 Multivariate Analysis of MRI Findings for Predicting Positive Resection Margin OR 95% CI P Size on MRI (cm) 1.24 0.83–1.84 0.288 Multifocality  Yes 2.04 0.52–7.99 0.308  No Ref Patterns of enhancing lesions  Mass without NME Ref  NME with or without mass 7.00 2.38–20.63 < 0.001 BPE  Weak Ref  Strong 2.59 0.91–7.42 0.076 ==== Refs 1 Fisher B Anderson S Bryant J Margolese RG Deutsch M Fisher ER Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer N Engl J Med 2002 347 1233 1241 12393820 2 Veronesi U Cascinelli N Mariani L Greco M Saccozzi R Luini A Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer N Engl J Med 2002 347 1227 1232 12393819 3 Singletary SE Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy Am J Surg 2002 184 383 393 12433599 4 Houssami N Macaskill P Marinovich ML Dixon JM Irwig L Brennan ME Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy Eur J Cancer 2010 46 3219 3232 20817513 5 Park AY Seo BK Real-time MRI navigated ultrasound for preoperative tumor evaluation in breast cancer patients: technique and clinical implementation Korean J Radiol 2016 17 695 705 27587958 6 Azu M Abrahamse P Katz SJ Jagsi R Morrow M What is an adequate margin for breast-conserving surgery? Surgeon attitudes and correlates Ann Surg Oncol 2010 17 558 563 19847566 7 Bani MR Lux MP Heusinger K Wenkel E Magener A Schulz-Wendtland R Factors correlating with reexcision after breast-conserving therapy Eur J Surg Oncol 2009 35 32 37 18539425 8 Lovrics PJ Cornacchi SD Farrokhyar F Garnett A Chen V Franic S The relationship between surgical factors and margin status after breast-conservation surgery for early stage breast cancer Am J Surg 2009 197 740 746 18789424 9 Park S Park HS Kim SI Koo JS Park BW Lee KS The impact of a focally positive resection margin on the local control in patients treated with breast-conserving therapy Jpn J Clin Oncol 2011 41 600 608 21355001 10 Melstrom LG Melstrom KA Wang EC Pilewskie M Winchester DJ Ductal carcinoma in situ: size and resection volume predict margin status Am J Clin Oncol 2010 33 438 442 20023569 11 Seo M Cho N Bae MS Koo HR Kim WH Lee SH Features of undiagnosed breast cancers at screening breast MR imaging and potential utility of computer-aided evaluation Korean J Radiol 2016 17 59 68 26798217 12 Chen SQ Huang M Shen YY Liu CL Xu CX Abbreviated MRI protocols for detecting breast cancer in women with dense breasts Korean J Radiol 2017 18 470 475 28458599 13 Chung A Saouaf R Scharre K Phillips E The impact of MRI on the treatment of DCIS Am Surg 2005 71 705 710 16468502 14 Del Frate C Borghese L Cedolini C Bestagno A Puglisi F Isola M Role of pre-surgical breast MRI in the management of invasive breast carcinoma Breast 2007 16 469 481 17433681 15 Schnall M MR imaging evaluation of cancer extent: is there clinical relevance? Magn Reson Imaging Clin N Am 2006 14 379 381 vii 17098178 16 Wolff AC Hammond ME Schwartz JN Hagerty KL Allred DC Cote RJ American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer J Clin Oncol 2007 25 118 145 17159189 17 Edge SB Byrd DR Compton CC Fritz AG Greene FL Trotti A AJCC cancer staging manual 7th ed New York, NY Springer 2010 18 D'Orsi CJ Sickles EA Mendelson EB Morris EA ACR BI-RADS atlas, breast imaging reporting and data system Reston, VA American College of Radiology 2013 19 Camp ER McAuliffe PF Gilroy JS Morris CG Lind DS Mendenhall NP Minimizing local recurrence after breast conserving therapy using intraoperative shaved margins to determine pathologic tumor clearance J Am Coll Surg 2005 201 855 861 16310688 20 Turnbull L Brown S Harvey I Olivier C Drew P Napp V Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial Lancet 2010 375 563 571 20159292 21 Houssami N Turner R Morrow M Preoperative magnetic resonance imaging in breast cancer: meta-analysis of surgical outcomes Ann Surg 2013 257 249 255 23187751 22 Pengel KE Loo CE Teertstra HJ Muller SH Wesseling J Peterse JL The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study Breast Cancer Res Treat 2009 116 161 169 18807269 23 Mann RM Loo CE Wobbes T Bult P Barentsz JO Gilhuijs KG The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast Breast Cancer Res Treat 2010 119 415 422 19885731 24 Kim OH Kim SJ Lee JS Enhancing patterns of breast cancer on preoperative dynamic contrast-enhanced magnetic resonance imaging and resection margin in breast conserving therapy Breast Dis 2016 36 27 35 27177341 25 Jang M Kim SM Yun BL Kim SW Kang EY Park SY Magnetic resonance imaging factors predicting re-excision in breast cancer patients having undergone conserving therapy J Korean Soc Magn Reson Med 2014 18 133 143 26 Sakamoto N Tozaki M Higa K Tsunoda Y Ogawa T Abe S Categorization of non-mass-like breast lesions detected by MRI Breast Cancer 2008 15 241 246 18224381 27 Tozaki M Fukuda K High-spatial-resolution MRI of non-masslike breast lesions: interpretation model based on BI-RADS MRI descriptors AJR Am J Roentgenol 2006 187 330 337 16861534 28 Vag T Baltzer PA Dietzel M Benndorf M Gajda M Camara O Kinetic characteristics of ductal carcinoma in situ (DCIS) in dynamic breast MRI using computer-assisted analysis Acta Radiol 2010 51 955 961 20942728 29 Dillon MF Hill AD Quinn CM McDermott EW O'Higgins N A pathologic assessment of adequate margin status in breast-conserving therapy Ann Surg Oncol 2006 13 333 339 16474911 30 Miller AR Brandao G Prihoda TJ Hill C Cruz AB Jr Yeh IT Positive margins following surgical resection of breast carcinoma: analysis of pathologic correlates J Surg Oncol 2004 86 134 140 15170651 31 DiPiro PJ Krajewski KM Giardino AA Braschi-Amirfarzan M Ramaiya NH Radiology consultation in the era of precision oncology: a review of consultation models and services in the tertiary setting Korean J Radiol 2017 18 18 27 28096715 32 Seo M Ryu JK Jahng GH Sohn YM Rhee SJ Oh JH Estimation of T2* relaxation time of breast cancer: correlation with clinical, imaging and pathological features Korean J Radiol 2017 18 238 248 28096732 33 Park SY Kang DK Kim TH Does background parenchymal enhancement on MRI affect the rate of positive resection margin in breast cancer patients? Br J Radiol 2015 88 20140638 25429418 34 Millet I Pages E Hoa D Merigeaud S Curros Doyon F Prat X Pearls and pitfalls in breast MRI Br J Radiol 2012 85 197 207 22128131 35 Giess CS Yeh ED Raza S Birdwell RL Background parenchymal enhancement at breast MR imaging: normal patterns, diagnostic challenges, and potential for false-positive and false-negative interpretation Radiographics 2014 34 234 247 24428293 36 Shimauchi A Jansen SA Abe H Jaskowiak N Schmidt RA Newstead GM Breast cancers not detected at MRI: review of false-negative lesions AJR Am J Roentgenol 2010 194 1674 1679 20489112